Health Care [ 4/12 ] | Biotechnology [ 18/72 ]
NYSE | Common Stock
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements.
Its portfolio of brands includes Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum.
The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022.
Haleon plc was incorporated in 2021 and is headquartered in Weybridge, the United Kingdom.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 2, 24 | 0.10 Increased by +22.40% | 0.09 Increased by +11.11% |
| May 1, 24 | 10.34 Increased by +9.72 K% | 8.81 Increased by +17.37% |
| Feb 29, 24 | 6.54 Increased by +5.64 K% | 10.27 Decreased by -36.32% |
| Nov 2, 23 | 0.11 Increased by +23.46% | 0.11 Decreased by -3.39% |
| Aug 2, 23 | 0.08 Increased by +72.73% | 0.10 Decreased by -19.11% |
| May 3, 23 | 0.11 | 0.13 Decreased by -19.37% |
| Mar 2, 23 | 0.11 | - |
| Nov 10, 22 | 0.09 | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 2.80 B Decreased by -3.25% | 365.00 M Increased by +5.80% | Increased by +13.05% Increased by +9.35% |
| Jun 30, 23 | 2.75 B Increased by +7.46% | 298.00 M Increased by +48.26% | Increased by +10.83% Increased by +37.97% |
| Mar 31, 23 | 2.99 B Increased by +13.67% | 389.00 M Increased by +13.41% | Increased by +13.03% Decreased by -0.22% |
| Dec 31, 22 | 3.79 B Increased by +158.91% | 198.00 M Decreased by -62.50% | Increased by +5.22% Decreased by -85.52% |
| Sep 30, 22 | 2.89 B Increased by +16.14% | 345.00 M Decreased by -7.01% | Increased by +11.93% Decreased by -19.93% |
| Jun 30, 22 | 2.56 B Increased by +N/A% | 201.00 M Increased by +N/A% | Increased by +7.85% - |
| Mar 31, 22 | 2.63 B Increased by +13.92% | 343.00 M Increased by +47.21% | Increased by +13.06% Increased by +29.22% |
| Dec 31, 21 | 1.47 B - | 528.00 M - | Increased by +36.04% - |